Andrew J. Burnham

Andrew J. Burnham

Auto-generated profile, based on publicly available information

Andrew J. Burnham

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
PDPaola Debenedictis
Paola Debenedictis
SSStacey Schultz-Cherry
Stacey Schultz-Cherry
ABAndrew Burnham
Andrew Burnham
GCGiovanni Cattoli
Giovanni Cattoli

1 November 2013 in Antiviral Research
Verified
Journal Article
Closed access
ABAndrew J. Burnham
Andrew J. Burnham
TBTatiana Baranovich
Tatiana Baranovich
EGElena Govorkova
Elena Govorkova

1 May 2013 in Antiviral Research
Verified
Journal Article
Closed access
EGElena Govorkova
Elena Govorkova
TBTatiana Baranovich
Tatiana Baranovich
PSPatrick Seiler
Patrick Seiler
JAJianling Armstrong
Jianling Armstrong
ABAndrew Burnham
Andrew Burnham
RWRobert G. Webster
Robert G. Webster

1 October 2007 in Virology
Verified
Journal Article
Closed access
ABAndrew J. Burnham
Andrew J. Burnham
LGLei Gong
Lei Gong
RHRichard W. Hardy
Richard W. Hardy

14 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VMVictoria A. Meliopoulos
Victoria A. Meliopoulos
GKGhazi Kayali
Ghazi Kayali
ABAndrew Burnham
Andrew Burnham
COChristine M. Oshansky
Christine M. Oshansky
PTPaul G Thomas
Paul G Thomas
SSStacey Schultz-Cherry
Stacey Schultz-Cherry
Astroviruses are a leading cause of gastroenteritis in mammals and birds worldwide. Although historically thought to be species-specific, increasing evidence suggests that astroviruses may cross species barriers. In this report, we used enzyme-linked immunosorbent assays to screen sera from three distinct human cohorts involved in influenza studies in Memphis, TN or Chapel Hill, NC, and Midwestern poultry abattoir workers for antibodies to turkey astrovirus type 2 (TAstV-2). Surprisingly, 26% of one cohort’s population was TAstV-2 positive as compared to 0 and 8.9% in the other cohorts. This cohort was composed of people with exposure to turkeys in the Midwestern United States including abattoir workers, turkey growers, and non-occupationally exposed participants. The odds of testing positive for antibodies against turkey astrovirus among abattoir workers were approximately 3 times higher than the other groups. These studies suggest that people with contact to turkeys can develop serological responses to turkey astrovirus. Further work is needed to determine if these exposures result in virus replication and/or clinical disease.

1 May 2014 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
ABAndrew J. Burnham
Andrew J. Burnham
TBTatiana Baranovich
Tatiana Baranovich
BMBindumadhav M. Marathe
Bindumadhav M. Marathe
JAJianling Armstrong
Jianling Armstrong
RWRobert G. Webster
Robert G. Webster
EGElena Govorkova
Elena Govorkova
Influenza B viruses cause annual outbreaks of respiratory illness in humans and are increasingly recognized as a major cause of influenza-associated pediatric mortality. Neuraminidase (NA) inhibitors (NAIs) are the only available therapy for patients infected with influenza B viruses, and the potential emergence of NAI-resistant viruses is a public health concern. The NA substitutions located within the enzyme active site could not only reduce NAI susceptibility of influenza B virus but also affect virus fitness. In this study, we investigated the effect of single NA substitutions on the fitness of influenza B/Yamanashi/166/1998 viruses (Yamagata lineage). We generated recombinant viruses containing either wild-type (WT) NA or NA with a substitution in the catalytic (R371K) or framework (E119A, D198E, D198Y, I222T, H274Y, and N294S) residues. We assessed NAI susceptibility, NA biochemical properties, NA protein expression, and virus replication in vitro and in differentiated normal human bronchial epithelial (NHBE) cells. Our results showed that four NA substitutions (D198E, I222T, H274Y, and N294S) conferred reduced inhibition by oseltamivir and three (E119A, D198Y, and R371K) conferred highly reduced inhibition by oseltamivir, zanamivir, and peramivir. All NA substitutions, except for D198Y and R371K, were genetically stable after seven passages in MDCK cells. Cell surface NA protein expression was significantly increased by H274Y and N294S substitutions. Viruses with the E119A, I222T, H274Y, or N294S substitution were not attenuated in replication efficiency in vitro or in NHBE cells. Overall, viruses with the E119A or H274Y NA substitution possess fitness comparable to NAI-susceptible virus, and the acquisition of these substitutions by influenza B viruses should be closely monitored.